(Crain’s) — CME Group Inc. stock rose 2.2% Thursday after a Goldman Sachs Group Inc. analyst raised his rating to a “buy,” citing a regulatory push to clear more over-the-counter derivatives through regulated entities like CME. CME’s open interest — the number of contracts that ...
Copyright CRAIN - Crain's
